Learn how an established immunology brand overcame prescription abandonment through real-time patient engagement moments after e-prescribing happens.

Starting self-injection therapy requires immediate support, even for mature specialty medications. With the Timely^SM by DrFirst^® end-to-end engagement platform, the brand was able to deliver personalized patient messages on behalf of providers, leading to:

• 2.64% incremental improvement in first-fill rates 

• 7% of patients reached out with therapy-related questions 

Download the full success story to see what’s possible.